Clinical Research in Australia
Australia is the world’s fastest growing destination for clinical research due to its high quality facilities, globally-renowned CROs and the government R&D tax incentive scheme.
The unique strength of Australia for global clinical research are:
The global portability of Australian clinical data (>70% of all FDA submissions have some Australian data within them since 2019)
The speed to commence clinical trials in Australia (typically under 8 weeks)
The sheer cost savings as compared to the USA, EU or UK (typically half the price or less)
The access to the Australian Government R&D Tax Incentive which is up to a further 43.5% cash rebate on all research costs for work performed in Australia
CROs in Australia
Australia’s Clinical Research Organizations (CROs) are renowned for their expertise, innovation, and commitment to delivering high-quality clinical research services.
INGENU CRO
Known for innovative and efficient clinical trial management and execution.
Novotech
Renowned for its comprehensive service offerings across the Asia-Pacific region.
Avance Clinical
Specializes in delivering high-quality clinical trials with a focus on rapid startup times.
CDMOs in Australia
Contract Development and Manufacturing Organizations (CDMOs) in Australia play a pivotal role in the pharmaceutical supply chain by offering specialized services that encompass the design, development, and manufacturing of drugs.
IDT Melbourne
Ab Initio Sydney
Mayne Adelaide
Bioanalytical labs in Australia
Australia has high quality bioanalytical labs, which are FDA Audited, NATA accredited and GLP compliant.
Agilex Biolabs
Australia’s most technologically advanced bioanalytical laboratory for clinical trials.
Resolian
Specialized in providing high-quality research and regulatory services. Clinical Sites & Networks
Phase 1 Clinical Research Units in Australia
Australia hosts a diverse range of clinical trial sites that are equipped to handle the complexities of both early and late-phase studies.
Nucleus Network
Australia’s largest phase 1 clinical trial site, with a focus on early-stage clinical development.
Cmax
Offers extensive expertise in conducting a wide range of clinical trials.
Linear
A leader in phase 1 clinical trials, based in Perth, Western Australia.
Phase 2 and 3 Clinical Sites in Australia
Australia has high quality bioanalytical labs, which are FDA Audited, NATA accredited and GLP compliant.
Emeritus
Momentum
Vitalis
Life science VCs in Australia
Venture capital investment in life sciences within Australia is vibrant and critical to the growth of innovation in biotechnology and healthcare. Australian life science VCs are active in nurturing startups and established companies alike, providing not only capital but also strategic guidance and access to international networks.
Life Science Sites in Australia
Clendon Biotech Capital
Brandon Capital Partners
GBS Ventures
